» Articles » PMID: 32437093

Childhood Central Nervous System Tumors and Leukemia: Incidence and Familial Risk. A Comparative Population-based Study in Utah and Norway

Overview
Date 2020 May 22
PMID 32437093
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Background: In this study, we aimed to evaluate incidence rates and family risk of the most common childhood cancers, tumors in the central nervous system (CNS), and leukemia among individuals from Norway and individuals with Scandinavian ancestry living in Utah.

Methods: We used the Utah Population Database and the Norwegian National Population Register linked to Cancer registries to identify cancers in children born between 1966 and 2015 and their first-degree relatives. We calculated incidence rates and hazards ratios.

Results: The overall incidence of CNS tumors increased with consecutive birth cohorts similarly in Utah and Norway (both P < 0.001). Incidence rates of leukemia were more stable and similar in both Utah and in Norway with 4.6/100 000 person-years among children (<15 years) born in the last cohort. A family history of CNS tumors was significantly associated with risk of childhood CNS tumors in Utah HR = 3.05 (95% CI 1.80-5.16) and Norway HR = 2.87 (95% CI 2.20-3.74). In Norway, children with a first-degree relative diagnosed with leukemia had high risk of leukemia (HR = 2.39, 95% CI 1.61-3.55).

Conclusion: Despite geographical distance and assumed large lifestyle differences, two genetically linked pediatric populations show similar incidences of CNS tumors and leukemia in the period 1966-2015. CNS tumors and leukemia aggregated in families in both countries.

Citing Articles

CBTRUS Statistical Report: Pediatric Brain Tumor Foundation Childhood and Adolescent Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2014-2018.

Ostrom Q, Price M, Ryan K, Edelson J, Neff C, Cioffi G Neuro Oncol. 2022; 24(Suppl 3):iii1-iii38.

PMID: 36066969 PMC: 9447434. DOI: 10.1093/neuonc/noac161.

References
1.
Barrington-Trimis J, Cockburn M, Metayer C, Gauderman W, Wiemels J, McKean-Cowdin R . Trends in childhood leukemia incidence over two decades from 1992 to 2013. Int J Cancer. 2016; 140(5):1000-1008. PMC: 5550103. DOI: 10.1002/ijc.30487. View

2.
Belson M, Kingsley B, Holmes A . Risk factors for acute leukemia in children: a review. Environ Health Perspect. 2007; 115(1):138-45. PMC: 1817663. DOI: 10.1289/ehp.9023. View

3.
Li J, Thompson T, Miller J, Pollack L, Stewart S . Cancer incidence among children and adolescents in the United States, 2001-2003. Pediatrics. 2008; 121(6):e1470-7. DOI: 10.1542/peds.2007-2964. View

4.
Steliarova-Foucher E, Colombet M, Ries L, Moreno F, Dolya A, Bray F . International incidence of childhood cancer, 2001-10: a population-based registry study. Lancet Oncol. 2017; 18(6):719-731. PMC: 5461370. DOI: 10.1016/S1470-2045(17)30186-9. View

5.
Valdez J, Nichols K, Kesserwan C . Li-Fraumeni syndrome: a paradigm for the understanding of hereditary cancer predisposition. Br J Haematol. 2016; 176(4):539-552. DOI: 10.1111/bjh.14461. View